Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcoholism | 10 | 2020 | 1109 | 2.900 |
Why?
|
| Drug-Seeking Behavior | 6 | 2020 | 213 | 2.360 |
Why?
|
| Reward | 9 | 2020 | 201 | 2.090 |
Why?
|
| Ethanol | 11 | 2022 | 892 | 1.810 |
Why?
|
| Behavior, Addictive | 4 | 2017 | 317 | 1.580 |
Why?
|
| Extinction, Psychological | 6 | 2020 | 240 | 1.490 |
Why?
|
| Alcohol Drinking | 5 | 2022 | 805 | 1.400 |
Why?
|
| Conditioning, Operant | 8 | 2019 | 241 | 1.340 |
Why?
|
| Prefrontal Cortex | 6 | 2020 | 639 | 1.290 |
Why?
|
| Sialic Acids | 2 | 2020 | 27 | 1.210 |
Why?
|
| Sex Characteristics | 4 | 2022 | 295 | 1.170 |
Why?
|
| Habits | 2 | 2018 | 14 | 1.140 |
Why?
|
| Central Nervous System Depressants | 4 | 2020 | 182 | 1.030 |
Why?
|
| Behavior, Animal | 3 | 2020 | 470 | 0.950 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 2 | 2014 | 6 | 0.930 |
Why?
|
| Neuralgia | 1 | 2022 | 27 | 0.880 |
Why?
|
| Chronic Pain | 1 | 2022 | 110 | 0.790 |
Why?
|
| Nucleus Accumbens | 4 | 2020 | 417 | 0.770 |
Why?
|
| Estrous Cycle | 1 | 2020 | 23 | 0.760 |
Why?
|
| Animals | 21 | 2022 | 20877 | 0.750 |
Why?
|
| Mice | 13 | 2022 | 8472 | 0.740 |
Why?
|
| Neurocognitive Disorders | 1 | 2019 | 23 | 0.710 |
Why?
|
| Hippocampus | 3 | 2020 | 471 | 0.690 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 284 | 0.650 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 2790 | 0.630 |
Why?
|
| Astrocytes | 1 | 2020 | 270 | 0.630 |
Why?
|
| Cues | 3 | 2017 | 654 | 0.580 |
Why?
|
| Conditioning, Classical | 4 | 2018 | 57 | 0.530 |
Why?
|
| Receptors, AMPA | 1 | 2015 | 99 | 0.520 |
Why?
|
| Neostriatum | 1 | 2015 | 60 | 0.520 |
Why?
|
| Cerebral Cortex | 1 | 2018 | 415 | 0.500 |
Why?
|
| Neurons | 2 | 2018 | 881 | 0.470 |
Why?
|
| Motivation | 1 | 2017 | 561 | 0.460 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 124 | 0.460 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2012 | 6 | 0.440 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 163 | 0.430 |
Why?
|
| Brain Chemistry | 1 | 2012 | 173 | 0.420 |
Why?
|
| HIV Infections | 1 | 2019 | 775 | 0.400 |
Why?
|
| Models, Theoretical | 1 | 2014 | 384 | 0.400 |
Why?
|
| Male | 17 | 2022 | 37281 | 0.400 |
Why?
|
| DNA Methylation | 1 | 2012 | 192 | 0.390 |
Why?
|
| Sex Chromosomes | 1 | 2010 | 4 | 0.380 |
Why?
|
| Self Administration | 3 | 2020 | 419 | 0.380 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 614 | 0.370 |
Why?
|
| Brain | 1 | 2020 | 2175 | 0.360 |
Why?
|
| Neural Pathways | 4 | 2018 | 323 | 0.320 |
Why?
|
| Disease Models, Animal | 4 | 2022 | 2550 | 0.320 |
Why?
|
| Biopsy, Needle | 2 | 2003 | 191 | 0.280 |
Why?
|
| Signal Transduction | 1 | 2015 | 2688 | 0.280 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 1241 | 0.260 |
Why?
|
| Female | 9 | 2022 | 38015 | 0.250 |
Why?
|
| Reinforcement Schedule | 2 | 2018 | 59 | 0.250 |
Why?
|
| Pulmonary Atelectasis | 1 | 2003 | 12 | 0.240 |
Why?
|
| Lung Neoplasms | 2 | 2003 | 1172 | 0.240 |
Why?
|
| Amygdala | 2 | 2017 | 159 | 0.240 |
Why?
|
| Carcinoma, Small Cell | 1 | 2003 | 53 | 0.240 |
Why?
|
| Hemoptysis | 1 | 2003 | 28 | 0.240 |
Why?
|
| Pneumothorax | 1 | 2003 | 42 | 0.230 |
Why?
|
| Hyperalgesia | 1 | 2022 | 18 | 0.220 |
Why?
|
| Analgesics | 1 | 2022 | 118 | 0.200 |
Why?
|
| Sweetening Agents | 1 | 2020 | 23 | 0.190 |
Why?
|
| Sucrose | 1 | 2020 | 58 | 0.190 |
Why?
|
| Inhalation Exposure | 1 | 2020 | 33 | 0.190 |
Why?
|
| Organ Specificity | 1 | 2020 | 167 | 0.190 |
Why?
|
| Glycosylation | 1 | 2020 | 185 | 0.180 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 187 | 0.180 |
Why?
|
| Neoplasm Staging | 1 | 2002 | 799 | 0.180 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2019 | 20 | 0.180 |
Why?
|
| Electroshock | 1 | 2019 | 36 | 0.180 |
Why?
|
| Dopamine Agents | 1 | 2019 | 56 | 0.170 |
Why?
|
| Appetitive Behavior | 1 | 2018 | 18 | 0.160 |
Why?
|
| Optogenetics | 1 | 2018 | 20 | 0.160 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1174 | 0.160 |
Why?
|
| Goals | 1 | 2018 | 65 | 0.150 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 98 | 0.150 |
Why?
|
| Humans | 9 | 2022 | 68525 | 0.150 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 517 | 0.150 |
Why?
|
| Dopamine | 1 | 2019 | 474 | 0.150 |
Why?
|
| Action Potentials | 1 | 2018 | 223 | 0.140 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 176 | 0.140 |
Why?
|
| Xanthenes | 1 | 2015 | 18 | 0.140 |
Why?
|
| Consummatory Behavior | 1 | 2015 | 8 | 0.140 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2015 | 59 | 0.130 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2015 | 64 | 0.130 |
Why?
|
| Cognition | 1 | 2019 | 512 | 0.130 |
Why?
|
| Amino Acids | 1 | 2015 | 131 | 0.130 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2015 | 128 | 0.130 |
Why?
|
| Comorbidity | 1 | 2019 | 1425 | 0.130 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 213 | 0.120 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2012 | 3 | 0.110 |
Why?
|
| Mice, Inbred ICR | 1 | 2012 | 44 | 0.110 |
Why?
|
| Glycoside Hydrolases | 1 | 2012 | 25 | 0.110 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 447 | 0.100 |
Why?
|
| Heart Arrest | 2 | 2009 | 113 | 0.100 |
Why?
|
| Disease Progression | 1 | 2014 | 1037 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2010 | 1039 | 0.100 |
Why?
|
| Sex-Determining Region Y Protein | 1 | 2010 | 2 | 0.100 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2010 | 6 | 0.100 |
Why?
|
| Orchiectomy | 1 | 2010 | 25 | 0.100 |
Why?
|
| Base Sequence | 1 | 2012 | 1015 | 0.100 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2010 | 22 | 0.090 |
Why?
|
| Food Preferences | 1 | 2010 | 46 | 0.090 |
Why?
|
| Models, Biological | 1 | 2014 | 981 | 0.090 |
Why?
|
| Avoidance Learning | 1 | 2010 | 58 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1446 | 0.090 |
Why?
|
| Neuronal Plasticity | 1 | 2012 | 274 | 0.090 |
Why?
|
| Sleep Deprivation | 1 | 2009 | 81 | 0.080 |
Why?
|
| Mental Disorders | 1 | 2014 | 659 | 0.080 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 218 | 0.080 |
Why?
|
| Body Weight | 1 | 2010 | 554 | 0.080 |
Why?
|
| Ischemia | 1 | 2009 | 229 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 1032 | 0.080 |
Why?
|
| Motor Activity | 1 | 2010 | 621 | 0.070 |
Why?
|
| Biomarkers | 1 | 2012 | 1593 | 0.070 |
Why?
|
| Rats | 3 | 2022 | 5300 | 0.070 |
Why?
|
| Drainage | 1 | 2003 | 133 | 0.060 |
Why?
|
| Inflammation | 1 | 2009 | 1030 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 1 | 2002 | 40 | 0.050 |
Why?
|
| Radiography | 1 | 2003 | 572 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2022 | 203 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2017 | 2083 | 0.050 |
Why?
|
| Mice, Inbred C3H | 2 | 2009 | 134 | 0.040 |
Why?
|
| Anxiety | 1 | 2022 | 422 | 0.040 |
Why?
|
| Endoscopy | 1 | 2002 | 464 | 0.040 |
Why?
|
| Cell Death | 2 | 2009 | 329 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 848 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2002 | 772 | 0.040 |
Why?
|
| Recurrence | 1 | 2017 | 948 | 0.030 |
Why?
|
| Time Factors | 2 | 2009 | 4655 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2009 | 31 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2009 | 164 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 88 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2009 | 77 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2009 | 72 | 0.020 |
Why?
|
| Aged | 1 | 2003 | 14842 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 455 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 1055 | 0.020 |
Why?
|
| Cytokines | 1 | 2009 | 866 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1293 | 0.010 |
Why?
|